Acute effect of metformin on exercise capacity in active males

Diabetes, Obesity and Metabolism

Volumn 10, Issue 9, 2008, Pages 747-754

  Johnson, S T ^a   Robert, C ^a   Bell, G J ^a   Bell, R Z ^a   Lewanczuk, R Z ^a   Boulé, Normand G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Exercise; Glucose; Lactase; Metformin; Oxygen consumption

Indexed keywords

GLUCOSE; LACTIC ACID; METFORMIN; OXYGEN; PLACEBO;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; BICYCLE ERGOMETER; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; DRUG MECHANISM; EXERCISE; EXERCISE INTENSITY; EXERCISE TEST; FLATULENCE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INDIGESTION; LACTATE BLOOD LEVEL; LUNG VENTILATION; MALE; NAUSEA; NORMAL HUMAN; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

EID: 50249114606     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2007.00805.x     Document Type: Article

References (27)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003; 27 (Suppl. 2): S1-s140.
2. Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycaemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2006; 49: 1711-1721.
3. Hermann LS, Nathan E, Ebbesen I. The influence of phenformin on lactate metabolism in diabetic patients in relation to hypoxia and exercise. Acta Med Scand 1973; 1-2: 111-116.
4. Guettler F, Petersen FB, Kjeldsen K. The influence of phenformin on blood lactic acid in normal and diabetic subjects during exercise. Diabetes 1963; 12: 420-423.
5. Botha JL, Vinik AI, Jackson WP. Association of lactic acidosis with biguanide therapy. S Afr Med J 1977; 52: 301-302.
6. Walker RS, Linton AL, Thomson WS. Mode of action and side-effects of phenformin hydrochloride. BMJ 1960; 2: 1567-1569.
7. Bjorntorp P, Carlstrom S, Fagerberg SE et al. Influence of phenformin and metformin on exercise induced lactataemia in patients with diabetes mellitus. Diabetologia 1978; 15: 95-98.
8. Shepardson CR, Christopher TG, Miller M. The effect of phenethylbiguanide on blood lactate levels following exercise. J Lab Clin Med 1962; 60: 1018.
9. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 2003; 163: 2594-2602.
10. Fery F, Plat L, Balasse EO. Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients. Metabolism 1997; 46: 227-233.
11. Hundal RS, Krssak M, Dufour S et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000; 49: 2063-2069.
12. Ivy JL. Role of carbohydrate in physical activity. Clin Sports Med 1999; 18: 469-484, v.
13. Musi N, Hirshman MF, Nygren J et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 2002; 51: 2074-2081.
14. Suwa M, Egashira T, Nakano H, Sasaki H, Kumagai S. Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo. J Appl Physiol 2006; 101: 1685-1692.
15. Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000; 348: 607-614.
16. BouléNG, Kenny GP, Haddad E, Wells GA, Sigal RJ. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in type 2 diabetes mellitus. Diabetologia 2003; 46: 1071-1081 (Epub 10 July 2003).
17. Fletcher GF, Balady GJ, Amsterdam EA et al. Exercise standards for testing and training: A statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 1694-1740.
18. Jadhav S, Ferrell W, Greer IA, Petrie JR, Cobbe SM, Sattar N. Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: A randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2006; 48: 956-963.
19. Samson BA, Howard LM, Raskin P, Hill DW. Effect of metformin on lactate levels during exercise performed by patients with diabetes. Appl Physiol Nutr Metab 2006; 31: S72.
20. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32: 77-97.
21. Bristol-Myers Squibb Company. Glucophage (Metformin Hydrochloride Tablets). Product Monograph, 2004.
22. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381.
23. Brunner GA, Ellmerer M, Sendlhofer G et al. Validation of home blood glucose meters with respect to clinical and analytical approaches. Diabetes Care 1998; 21: 585-590.
24. Buckley JD, Bourdon PC, Woolford SM. Effect of measuring blood lactate concentrations using different automated lactate analysers on blood lactate transition thresholds. J Sci Med Sport 2003; 6: 408-421.
25. Musi N, Yu H, Goodyear LJ. AMP-activated protein kinase regulation and action in skeletal muscle during exercise. Biochem Soc Trans 2003; 31 (Pt 1): 191-195.
26. Musi N, Fujii N, Hirshman MF et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 2001; 50: 921-927.
27. Zhou G, Myers R, Li Y et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-1174.